Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VORTIOXETINE HYDROBROMIDE, with a corresponding US DMF Number 31726.
Remarkably, this DMF maintains an Active status since its submission on June 01, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 05, 2017, and payment made on May 17, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II